Michael Pacanowski

2.0k total citations
66 papers, 1.3k citations indexed

About

Michael Pacanowski is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Pacanowski has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 17 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Pacanowski's work include Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (11 papers) and Statistical Methods in Clinical Trials (9 papers). Michael Pacanowski is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (11 papers) and Statistical Methods in Clinical Trials (9 papers). Michael Pacanowski collaborates with scholars based in United States, Thailand and Austria. Michael Pacanowski's co-authors include Issam Zineh, Robert J. Konrad, Guoqing Cao, Jason S. Troutt, Cody J. Peer, Carl J. Pepine, Hobart Rogers, Shawn D. Spencer, Robert N. Schuck and Rhonda M. Cooper‐DeHoff and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Michael Pacanowski

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pacanowski United States 21 349 319 290 249 219 66 1.3k
Georgia Ragia Greece 19 194 0.6× 441 1.4× 203 0.7× 216 0.9× 106 0.5× 62 1.1k
Sony Tuteja United States 20 320 0.9× 283 0.9× 229 0.8× 276 1.1× 73 0.3× 71 1.3k
Yue Qiu China 12 550 1.6× 247 0.8× 92 0.3× 185 0.7× 81 0.4× 25 1.1k
P. M. Ridker United States 8 149 0.4× 516 1.6× 344 1.2× 168 0.7× 109 0.5× 9 1.4k
Bennett Ma United States 16 489 1.4× 616 1.9× 83 0.3× 356 1.4× 172 0.8× 38 1.6k
Kyoung Soo Lim South Korea 22 161 0.5× 352 1.1× 152 0.5× 255 1.0× 237 1.1× 84 1.5k
Aleksi Tornio Finland 25 307 0.9× 883 2.8× 376 1.3× 295 1.2× 310 1.4× 68 1.9k
Jasmine A. Luzum United States 17 199 0.6× 247 0.8× 256 0.9× 176 0.7× 47 0.2× 50 870
Lloyd R. Whitfield United States 19 359 1.0× 216 0.7× 115 0.4× 222 0.9× 102 0.5× 48 1.2k
Joshua P. Lewis United States 22 225 0.6× 155 0.5× 414 1.4× 431 1.7× 181 0.8× 48 1.4k

Countries citing papers authored by Michael Pacanowski

Since Specialization
Citations

This map shows the geographic impact of Michael Pacanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pacanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pacanowski more than expected).

Fields of papers citing papers by Michael Pacanowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pacanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pacanowski. The network helps show where Michael Pacanowski may publish in the future.

Co-authorship network of co-authors of Michael Pacanowski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pacanowski. A scholar is included among the top collaborators of Michael Pacanowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pacanowski. Michael Pacanowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabarinath, Sreedharan, et al.. (2025). Trends in clinical studies evaluating neurofilament light chain as a biomarker. Biomarkers in Medicine. 19(17). 813–823.
2.
Li, Ruo‐Jing, et al.. (2025). Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis. Clinical and Translational Science. 18(3). e70176–e70176. 1 indexed citations
3.
Li, Ruo‐Jing, et al.. (2024). Clinical pharmacology considerations for first‐in‐human clinical trials for enzyme replacement therapy. Journal of Inherited Metabolic Disease. 47(5). 1096–1106. 1 indexed citations
4.
Schuck, Robert N., et al.. (2024). Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC). Orphanet Journal of Rare Diseases. 19(1). 280–280. 2 indexed citations
5.
Agrawal, Sundeep, William F. Pierce, Melanie Royce, et al.. (2024). FDA Approval Summary: Capecitabine Labeling Update under Project Renewal. Clinical Cancer Research. 30(24). 5508–5514.
6.
Hon, Yuen Yi, Jie Wang, Henrietta Abodakpi, et al.. (2023). Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism. Clinical and Translational Science. 16(12). 2438–2457. 6 indexed citations
7.
Pacanowski, Michael, et al.. (2023). A Multistakeholder Perspective on Advancing Individualized Therapeutics. Clinical Pharmacology & Therapeutics. 114(5). 994–1001. 1 indexed citations
8.
Wang, Jie, et al.. (2022). Dose-finding studies in drug development for rare genetic diseases. Orphanet Journal of Rare Diseases. 17(1). 156–156. 6 indexed citations
9.
Wilson, Jennifer L., Rebecca Racz, Tianyun Liu, et al.. (2018). PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development. PLoS Computational Biology. 14(12). e1006614–e1006614. 10 indexed citations
10.
Pacanowski, Michael, et al.. (2014). Next-Generation Medicines: Past Regulatory Experience and Considerations for the Future. Clinical Pharmacology & Therapeutics. 95(3). 247–249. 15 indexed citations
11.
Maliepaard, Marc, Charity Nofziger, Marisa Papaluca, et al.. (2013). Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective. Nature Reviews Drug Discovery. 12(2). 103–115. 50 indexed citations
12.
Racoosin, Judith A., David W. Roberson, Michael Pacanowski, & David R. Nielsen. (2013). New Evidence about an Old Drug — Risk with Codeine after Adenotonsillectomy. New England Journal of Medicine. 368(23). 2155–2157. 59 indexed citations
13.
Liu, Jiang, Pravin Jadhav, Shashi Amur, et al.. (2012). Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects. Hepatology. 57(3). 897–902. 9 indexed citations
14.
Lewis, Joshua P., Richard B. Horenstein, Kathleen A. Ryan, et al.. (2012). The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenetics and Genomics. 23(1). 1–8. 129 indexed citations
15.
Florian, Jeffry, Pravin Jadhav, Shashi Amur, et al.. (2012). Boceprevir dosing for late responders and null responders: The role of bridging data between treatment-naïve and -experienced subjects. Hepatology. 57(3). 903–907. 9 indexed citations
16.
Pacanowski, Michael, Michael A. Martin, Rhonda M. Cooper‐DeHoff, et al.. (2011). Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy. Pharmacogenetics and Genomics. 21(6). 333–340. 20 indexed citations
17.
Zineh, Issam, et al.. (2010). High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol. Journal of Lipid Research. 51(9). 2714–2721. 207 indexed citations
18.
Pacanowski, Michael, Issam Zineh, Haihong Li, et al.. (2008). Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Journal of Translational Medicine. 6(1). 11–11. 24 indexed citations
19.
Pacanowski, Michael, et al.. (2008). Plasma coenzyme Q10 predicts lipid-lowering response to high-dose atorvastatin. Journal of clinical lipidology. 2(4). 289–297. 13 indexed citations
20.
Pacanowski, Michael & Julie A. Johnson. (2007). PharmGKB Submission Update: IX. ADRB1 Gene Summary. Pharmacological Reviews. 59(1). 2–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgia Ragia Breakdown of academic impact, for papers by Sony Tuteja Breakdown of academic impact, for papers by Yue Qiu Breakdown of academic impact, for papers by P. M. Ridker Breakdown of academic impact, for papers by Bennett Ma Breakdown of academic impact, for papers by Kyoung Soo Lim Breakdown of academic impact, for papers by Aleksi Tornio Breakdown of academic impact, for papers by Jasmine A. Luzum Breakdown of academic impact, for papers by Lloyd R. Whitfield Breakdown of academic impact, for papers by Joshua P. Lewis
Rankless by CCL
2026